Literature DB >> 25388399

Isolation and culture of primary glioblastoma cells from human tumor specimens.

Sascha Seidel1, Boyan K Garvalov, Till Acker.   

Abstract

Cultured tumor cells are a central tool in cancer research and have provided fundamental insights in tumor biology. Recent evidence, however, indicates that classically established cell lines from different tumors, including glioblastoma, do not fully reflect the genotypes and phenotypes of the respective primary tumors. By contrast, primary cells, isolated from human tumor samples and maintained in serum-free spheroid cultures at low passage under defined growth factor conditions, reproduce key aspects of tumor cell physiology much more faithfully. Among the tumor cell characteristics that are better represented in primary glioblastoma cell cultures is the self-renewal and differentiation potential of the tumor cells. Indeed, a large body of evidence from the past decade indicates that glioblastomas and other tumors are composed of a hierarchy of heterogeneous types of cells, which are generated and maintained by cells that share characteristics of stem cells. This cancer stem cell/tumor initiating cell population is optimally preserved and maintained in primary glioblastoma cultures. Here, we describe a method for the isolation and culture of primary tumor cells from human glioblastomas in serum-free conditions, which allows the routine generation and proper maintenance of tumor cells as spheroid cultures. Such primary tumor cultures can serve as a model of choice for the study of the mechanisms behind key aspects of glioblastoma biology, including tumorigenicity, stem cell hierarchy, invasion, and therapeutic resistance.

Entities:  

Mesh:

Year:  2015        PMID: 25388399     DOI: 10.1007/978-1-4939-1785-3_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner.

Authors:  Silvia Würstle; Fabian Schneider; Florian Ringel; Jens Gempt; Friederike Lämmer; Claire Delbridge; Wei Wu; Jürgen Schlegel
Journal:  Oncol Lett       Date:  2017-05-02       Impact factor: 2.967

2.  Snail expression contributes to temozolomide resistance in glioblastoma.

Authors:  Huaxin Liang; Guangyong Chen; Jiayan Li; Fuwei Yang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.

Authors:  Nicolas Goffart; Arnaud Lombard; François Lallemand; Jérôme Kroonen; Jessica Nassen; Emmanuel Di Valentin; Sharon Berendsen; Matthias Dedobbeleer; Estelle Willems; Pierre Robe; Vincent Bours; Didier Martin; Philippe Martinive; Pierre Maquet; Bernard Rogister
Journal:  Neuro Oncol       Date:  2016-07-01       Impact factor: 12.300

4.  Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation.

Authors:  Kyoung Su Sung; Jin-Kyoung Shim; Ji-Hyun Lee; Se Hoon Kim; Sohee Park; Tae-Hoon Roh; Ju Hyung Moon; Eui-Hyun Kim; Sun Ho Kim; Su Jae Lee; Yong Min Huh; Seok-Gu Kang; Jong Hee Chang
Journal:  Cancer Cell Int       Date:  2016-09-27       Impact factor: 5.722

5.  Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events.

Authors:  Vladimir N Babenko; Natalya V Gubanova; Anatoly O Bragin; Irina V Chadaeva; Gennady V Vasiliev; Irina V Medvedeva; Alexey S Gaytan; Alexey L Krivoshapkin; Yuriy L Orlov
Journal:  J Integr Bioinform       Date:  2017-09-18

6.  Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.

Authors:  Zhenzhe Li; Jixing Zhang; Hongshan Zheng; Chenlong Li; Jinsheng Xiong; Weiliang Wang; Hongbo Bao; Hua Jin; Peng Liang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-28

Review 7.  Patient-Derived Cancer Organoids for Precision Oncology Treatment.

Authors:  Mark N Pernik; Cylaina E Bird; Jeffrey I Traylor; Diana D Shi; Timothy E Richardson; Samuel K McBrayer; Kalil G Abdullah
Journal:  J Pers Med       Date:  2021-05-17

8.  Extensive and systematic rewiring of histone post-translational modifications in cancer model systems.

Authors:  Roberta Noberini; Daniela Osti; Claudia Miccolo; Cristina Richichi; Michela Lupia; Giacomo Corleone; Sung-Pil Hong; Piergiuseppe Colombo; Bianca Pollo; Lorenzo Fornasari; Giancarlo Pruneri; Luca Magnani; Ugo Cavallaro; Susanna Chiocca; Saverio Minucci; Giuliana Pelicci; Tiziana Bonaldi
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

9.  The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior.

Authors:  Veronika Skarkova; Marketa Krupova; Barbora Vitovcova; Adam Skarka; Petra Kasparova; Petr Krupa; Vera Kralova; Emil Rudolf
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

10.  Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.

Authors:  Antonela Sofía Asad; Alejandro Javier Nicola Candia; Nazareno Gonzalez; Camila Florencia Zuccato; Araceli Abt; Santiago Jordi Orrillo; Yael Lastra; Emilio De Simone; Florence Boutillon; Vincent Goffin; Adriana Seilicovich; Daniel Alberto Pisera; María Jimena Ferraris; Marianela Candolfi
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.